These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 22437266)

  • 21. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
    Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
    J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and functional mapping of regional differences in P2Y receptor expression in the rat lens.
    Hu RG; Suzuki-Kerr H; Webb KF; Rhodes JD; Collison DJ; Duncan G; Donaldson PJ
    Exp Eye Res; 2008 Aug; 87(2):137-46. PubMed ID: 18617163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. UTP reduces infarct size and improves mice heart function after myocardial infarct via P2Y2 receptor.
    Cohen R; Shainberg A; Hochhauser E; Cheporko Y; Tobar A; Birk E; Pinhas L; Leipziger J; Don J; Porat E
    Biochem Pharmacol; 2011 Nov; 82(9):1126-33. PubMed ID: 21839729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development.
    Agresti C; Meomartini ME; Amadio S; Ambrosini E; Serafini B; Franchini L; Volonté C; Aloisi F; Visentin S
    Glia; 2005 Apr; 50(2):132-44. PubMed ID: 15657938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor.
    Hu B; Mei QB; Yao XJ; Smith E; Barry WH; Liang BT
    FASEB J; 2001 Dec; 15(14):2739-41. PubMed ID: 11606481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. P2Y isoforms operative in mouse taste cells.
    Bystrova MF; Yatzenko YE; Fedorov IV; Rogachevskaja OA; Kolesnikov SS
    Cell Tissue Res; 2006 Mar; 323(3):377-82. PubMed ID: 16328495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells.
    Buvinic S; Bravo-Zehnder M; Boyer JL; Huidobro-Toro JP; González A
    J Cell Sci; 2007 Dec; 120(Pt 24):4289-301. PubMed ID: 18057028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P2Y nucleotide receptor interaction with alpha integrin mediates astrocyte migration.
    Wang M; Kong Q; Gonzalez FA; Sun G; Erb L; Seye C; Weisman GA
    J Neurochem; 2005 Nov; 95(3):630-40. PubMed ID: 16135088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
    Alvarado-Castillo C; Harden TK; Boyer JL
    Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. UTP Regulates the Cardioprotective Action of Transplanted Stem Cells Derived From Mouse Cardiac Adipose Tissue.
    Diaz Villamil E; De Roeck L; Vanorlé M; Communi D
    Front Pharmacol; 2022; 13():906173. PubMed ID: 35784739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correction to 'Age-related changes in P2Y receptor signalling in mouse cochlear supporting cells'.
    J Physiol; 2024 Feb; 602(4):759. PubMed ID: 38265853
    [No Abstract]   [Full Text] [Related]  

  • 32. How selective antagonists and genetic modification have helped characterise the expression and functions of vascular P2Y receptors.
    Dales MO; Drummond RM; Kennedy C
    Purinergic Signal; 2024 May; ():. PubMed ID: 38740733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological interaction and immune response of purinergic receptors in therapeutic modulation.
    Kiaie SH; Hatami Z; Nasr MS; Pazooki P; Hemmati S; Baradaran B; Valizadeh H
    Purinergic Signal; 2024 Aug; 20(4):321-343. PubMed ID: 37843749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss-of-function N178T variant of the human P2Y
    Horckmans M; Diaz Villamil E; Verdier C; Laurell H; Ruidavets JB; De Roeck L; Combes G; Martinez LO; Communi D
    Front Pharmacol; 2022; 13():1049696. PubMed ID: 36532779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular Nucleotides Affect the Proangiogenic Behavior of Fibroblasts, Keratinocytes, and Endothelial Cells.
    Węgłowska E; Koziołkiewicz M; Kamińska D; Grobelski B; Pawełczak D; Kołodziejczyk M; Bielecki S; Gendaszewska-Darmach E
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efferocytosis of vascular cells in cardiovascular disease.
    Cabrera JTO; Makino A
    Pharmacol Ther; 2022 Jan; 229():107919. PubMed ID: 34171333
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of Macrophage Inflammation by P2Y Purinergic Receptors.
    Klaver D; Thurnher M
    Cells; 2021 May; 10(5):. PubMed ID: 34064383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purinergic Regulation of Endothelial Barrier Function.
    Aslam M; Gündüz D; Troidl C; Heger J; Hamm CW; Schulz R
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2Y Purinergic Receptors, Endothelial Dysfunction, and Cardiovascular Diseases.
    Strassheim D; Verin A; Batori R; Nijmeh H; Burns N; Kovacs-Kasa A; Umapathy NS; Kotamarthi J; Gokhale YS; Karoor V; Stenmark KR; Gerasimovskaya E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.
    Iborra-Egea O; Gálvez-Montón C; Roura S; Perea-Gil I; Prat-Vidal C; Soler-Botija C; Bayes-Genis A
    NPJ Syst Biol Appl; 2017; 3():12. PubMed ID: 28649439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.